Posts
Why is Elmet (ELMT) up ~36%? A $450m Pentagon cheque and a $2bn ceiling that isn't an order
Marvell Technology (MRVL): the full file — the numbers, the owners, and what the filings actually show
CSTL Castle Biosciences stock
**CSTL** Castle Biosciences stock, watch for a top of range breakout. Breakout trade * WATCH for possible breakout above 34.96 * Target: 39.65, 18.6% Stop: 31.93 Loss: 4.5% * P/L ratio: 4.1 : 1 - Excellent BULLISH * \[Timing\] Strong bullish 3 day candlestick pattern. * \[Timing\] Long trade quality …
Oh the money is GONE gone 💀
Moscow Mitch is back
Top stocks hitting 52-Week Highs/Lows - September 14, 2026 📈 📉
## 📈 52-Week Highs: The 52-Week Highs list shows stocks that have reached their highest price point in the past 52 weeks during the trading session. | Symbol | Name | Price | Year High | Market Cap | |:-------|:-----|:-----:|:---------:|:----------:| | [CVX](https://marketrodeo.com/asset/CVX) | Chevron Corporation | $212.16 | $217.65 | …
High Tide’s revenue hit $199 million, a fifth straight quarterly record !
* **RECORD** Quarterly Revenue of $199 Million and Annualized Revenue Run Rate of Approximately $800 Million * **RECORD** Gross Profit of $52.7 Million * **RECORD** Adjusted EBITDA of $16.2 Million * **RECORD** Income From Operations of $8.7 Million * **RECORD** Net Income of $12.7 Million * **RECORD** Cash Flow From …
Donald Trump Jr.’s Wedding Bankrolled by Putin-Linked Russian Oligarch
On May 24, Donald Trump Jr. was celebrating in the Bahamas, as scantily clad dancers in stilettos and sailor caps performed for him and his guests. It was the last night of his wedding, a lavish, three-day party held across a pair of ultra-exclusive private islands. A five-tier funfetti cake …
TAX AI LIKE A HUMAN
If AI is taking the jobs of humans. We must treat it like a human and tax it. Same for corporations. Call your representatives!
Did You Own Cassava Sciences ($SAVA) During Its 15% Drop? Investors Settlement Is Available Now
Hey guys, if you missed it, the court finally approved the $31.25M settlement between Cassava Sciences and its investors over claims that the company misled investors about simufilam’s supporting research, data-management controls, and prospects. Here’s a quick recap. In 2023, Cassava was accused of failing to disclose problems with the …